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In this study, we address the function of Transforming Growth Factor beta (TGF-β) and its type II receptor (Tgfbr2) in limb development in
vivo. Mouse embryos were generated in which the Tgfbr2 gene was deleted in early limb mesenchyme using Prx1Cre-mediated LoxP
recombination. A high level of Tgfbr2 gene deletion was verified in limb mesenchyme by PCR between E9.5 and E10.5 days in Cre expressing
mice. RT-PCR assays indicated a significant depletion of Tgfbr2 mRNA by E10.5 days as a result of Cre mediated gene deletion. Furthermore,
limb mesenchyme from Cre+;Tgfbr2f/f mice placed in micromass culture did not respond to exogenously added TGF-β1 confirming the functional
deletion of the receptor. However, there was an unexpected increase in the number and intensity of Alcian blue stained chondrogenic nodules in
micromass cultures derived from Tgfbr2-deleted limbs relative to cultures from control limbs suggesting that Tgfbr2 normally limits
chondrogenesis in vitro. In vivo, early limb development and chondrocyte differentiation occurred normally in Tgfbr2-depleted mice. Later in
development, depletion of Tgfbr2 in limb mesenchyme resulted in short limbs and fusion of the joints in the phalanges. Alteration in the length of
the long bones was primarily due to a decrease in chondrocyte proliferation after E13.5 days. In addition, the transition from prehypertrophic to
hypertrophic cells was accelerated while there was a delay in late hypertrophic differentiation leading to a reduction in the length of the marrow
cavity. In the joint, cartilage cells replaced interzone cells during development. Analysis of markers for joint development indicated that the joint
was specified properly and that the interzone cells were initially formed but not maintained. The results suggest that Tgfbr2 is required for normal
development of the skeleton and that Tgfbr2 can act to limit chondrogenesis in mesenchymal cells like the interzone.
© 2007 Elsevier Inc. All rights reserved.Keywords: Micromass culture; Tgfbr2; Chondrocyte; Synovial joint; Sternum; SkullIntroduction
Transforming Growth Factor β (TGF-β) signaling regulates
diverse cellular processes, such as cell growth, differentiation,
proliferation, and formation of extracellular matrix during
embryonic development (Dunker and Krieglstein, 2000;
Mummery, 2001; Serra and Chang, 2003; Verrecchia and
Mauviel, 2002). Members of the TGF-β superfamily include
TGF-β isoforms (TGF-β1, 2, 3), the Activins and Inhibins,
Bone Morphogenetic Protein (BMP), and Growth and Differ-
entiation Factors (GDF). Members of the TGF-β superfamily
signal through heteromeric serine threonine kinases composed
of Type I and Type II receptors. TGF-β signaling is initiated⁎ Corresponding author. Fax: +1 205 975 5648.
E-mail address: rserra@uab.edu (R. Serra).
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doi:10.1016/j.ydbio.2007.07.040when ligand binds to the type II receptor (Tgfbr2) on the cell
surface (Massague, 1998). Ligand binding recruits the type I
receptor (Tgfbr1) to form a heterotetrameric complex of two
type I and two type II receptors. Tgfbr2 is a constitutively active
serine/threonine kinase. The formation of the complex enables
Tgfbr2 to phosphorylate the GS domain of Tgfbr1, activating its
serine/threonine kinase. Smad proteins are downstream targets
of the type I receptor kinase. Activated Smad proteins
translocate into nucleus to induce cellular responses by acting
as transcription factors (Feng and Derynck, 2005; Massague,
1998).
Endochondral bone is formed by a series of consecutive and
strictly regulated differentiation steps (de Crombrugghe et al.,
2000; Goldring et al., 2006; Lefebvre and Smits, 2005).
Chondrogenesis is the earliest step for endochondral bone
formation. It begins with the condensation of undifferentiated
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During this process, undifferentiated progenitor cells differ-
entiate into chondrocytes expressing type II collagen as well as
cartilage specific proteoglycans. These two cellular processes,
in fact, occur almost at the same time and result in the formation
of a cartilage template for future bone formation. Differentiated
chondrocytes then undergo maturation and hypertrophic
differentiation. Eventually, the cartilage template is replaced
by bone. One of the most well characterized properties of
cartilage is the elaboration of a specific extracellular matrix
(ECM) that can stain with peanut agglutinin (PNA) and Alcian
blue (Bagnall and Sanders, 1989; DeLise and Tuan, 2002;
Stringa and Tuan, 1996).
Previously it was shown that BMPs are critical for early
stages of endochondral bone formation. The majority of skeletal
elements were absent in mice deficient in both BMP type I
receptors, Bmpr1a and Bmpr1b (Yoon et al., 2005). It was
determined that BMP is required for chondrocyte proliferation,
survival, and differentiation. Based on gain-of-function studies
in cell culture models, it has been suggested that TGF-β triggers
chondrogenesis and that BMP maintains and promotes the
differentiated phenotype (Carrington and Reddi, 1990; Chimal-
Monroy and Diaz de Leon, 1997; Kulyk et al., 1989; Leonard et
al., 1991;Macias et al., 1999; Roark and Greer, 1994; Verrecchia
and Mauviel, 2002). The conclusions were based on the
observation that treatment with TGF-β resulted in increased
Alcian blue staining and expression of type II collagen even
though the cells did not obtain chondrocyte morphology,
meaning treatment with TGF-β resulted in a continuous sheet
of Alcian blue staining and the cells remained spindle shaped
(Chimal-Monroy andDiaz de Leon, 1997). In contrast, treatment
with BMP or GDF5 resulted in the formation of discreet Alcian
blue stained nodules containing cells with typical round
chondrocyte morphology (Denker et al., 1999; Hatakeyama et
al., 2004; Kulyk et al., 1989). These results led us to investigate
the function of TGF-β in limb development using a loss of
function model. For these experiments, the Tgfbr2 gene was
deleted in mouse limb mesenchyme using Prx1-cre mediated
recombination. The expression pattern of Cre recombinase in
Prx1-cre mice was previously shown using the Z/AP reporter
mouse line in which the histochemical marker human placental
alkaline phosphatase is transcriptionally activated following
Cre-mediated recombination (Logan et al., 2002). At 9.5 days of
gestation, the first expression of alkaline phosphatase reporter
was shown in the forelimb mesenchyme. By E10.5 days,
transgenic embryos showed complete recombination of the
reporter in both forelimb and hindlimb mesenchyme. Cre
recombinase activity was not detected in the apical ectodermal
ridge (AER) or any of the limb ectoderm. Activity was also
detected in cranial mesoderm as well as ventral mesoderm in the
trunk. Here, we show maximal deletion of Tgfbr2 exon 2 DNA
in limb mesenchyme from Prx1Cre+;Tgfbr2f/f mice between
E9.5 and E10.5 days. Furthermore, cells from Tgfbr2-deleted
limbs did not respond to TGF-β1 indicating functional deletion
of the receptor. Nevertheless, early limb development occurred
normally. That is, the mesenchyme condensed in the correct
pattern and Sox9 protein was expressed normally. However, byE15.5 days, defects in the development of the limbs were
apparent. The limbs were shorter than controls, the deltoid
tuberosity was missing, and the joints of the phalanges were
fused. Reduced limb length was shown to be primarily the result
of reduced chondrocyte proliferation after E13.5 days. In the
developing joint, cartilage replaced the interzone cells leading to
joint fusion. Marker analysis indicated that the interzone was
initially formed but was not maintained. Since interzone cells
were replaced with cartilage and mesenchyme from Tgfbr2-
depleted limbs grown in micromass culture formed more
discreet Acian blue stained chondrogenic nodules than Tgfbr2-
containing controls, we propose that Tgfbr2 normally limits
chondrogenic differentiation in mesenchymal cells including the
interzone. Together the results suggest that Tgfb2 is required for
normal skeletal development.Materials and methods
Mouse crosses
Mice in which exon2 of Tgfbr2 was flanked with loxP sites (Tgfbr2f/f ) were
obtained from Dr. H.L Moses, Vanderbilt University, Nasshville, TN (Chytil et
al., 2002). Tgfbr2f/f mice were mated to transgenic mice that express Cre under
the control of the Prx1 promoter (obtained from Dr. Clifford J. Tabin, Harvard
Medical School, Boston, Massachusetts; Logan et al., 2002) to create a mouse in
which Tgfbr2 is deleted in early limb mesenchyme. The genotype of adult
transgenic mice was determined by PCR analysis of genomic DNA isolated
from tail biopsies. Embryos were genotyped using DNA isolated from one of the
limb buds by proteinase K digestion. PCR for the Cre transgene was performed
using two different primer sets: Cre5V (TGC TCT GTC CGT TTG CCG),
Cre3V (ACT GTG TCC AGA CCA GGC), Prx1CreF (AGG AGG TAG GAG
ATT GTG ATG GAG), and Prx1 CreR (ACC GGC AAA CGG ACA GAA
GCATTT). Genomic DNAwas amplified for 30 cycles of denaturation at 94 °C
for 30 s, annealing at 58 °C for 60 s, and elongation for 90 s at 72 °C in reaction
buffer containing 2.5 mM MgCl2, 1× PCR buffer (HotMaster Taq buffer,
Eppendorf), 0.2 mM dNTPs (Pharmacia, Uppsala, Sweden), 0.2 μM each
primer. The loxP allele and deletion of the target gene were identified using the
following primers (Fig. 5A): 8w-a (TAA ACA AGG TCC GGA GCC CA) and
LA-LoxP (ACT TCT GCA AGA GGT CCC CT). Two bands can be detected
with these primers. One band represents the wild-type allele (420 bp); another
band represents the loxP allele (540 bp). The presence of both bands indicates a
mouse that is heterozygous for the loxP allele. To detect recombination and the
subsequent loss of the floxed allele (Tgfbr2), CldelR (AGA GTG AAG CCG
TGG TAGGTGAGC TTG) was added to reactions as a third primer. Successful
recombination was confirmed by the presence of a 610-bp band (Baffi et al.,
2004).
RT PCR
mRNA was extracted from limbs of E9.5, 10.5, 11.5, and 12.5 days mice
using the standard Trizol method. Cells were lysed with Trizol and RNA was
precipitated in ethanol. RNA concentration was determined by UV spectro-
photometry. For RT-PCR analysis, cDNA was synthesized from 1 μg of total
mRNA using random primers. PCR for tgfb1, 2, and 3, Tgfbr2, and 18S was
performed using the following primers: tgfb1 primers (forward 5′-GCT AAT
GGT GGA CCG CAA CAA C-3′ and reverse 5′-CAC TGC TTC CCG AAT
GTC TGA C-3′), Tgfb2 primers (forward 5′-CTT CAC CAC AAA GAC AGG
AAC CTG G-3′ and reverse 5′-CCT GCT AAT GTT GTT GCC CTC CTA C-
3′), tgfbr2 exon2 primers (forward 5′-TTA ACA GTG ATG TCA TGG CCA
GCG-3′ and reverse 5′-AGA CTT CAT GCG GCT TCT CAC AGA-3′), tgfbr2
exon2–3 primers (5′-CCA CTT GCG ACA CCG AGA AGT-3′ and reverse 5′-
GCA CAC ATG AAG AAA GTC TCG C-3′), Sox9 primers (forward 5′-GAG
AAA AGC TAT GGT GAC AGA GC-3′ and reverse 5′-GTC CTC CAT GTT
AAC TCT GAA GG-3′), 18S primers (forward 5′-ACG GAA GGG CAC CAC
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10–200 ng of cDNA was amplified for 20–35 cycles in reaction buffer
containing 2.5 mM MgCl2, 1× PCR buffer (HotMaster Taq buffer, Eppendorf),
0.2 mM dNTPs (Pharmacia, Uppsala, Sweden), 0.2 μM each primer (Pharmacia,
Uppsala, Sweden). The linear range of product formation was determined by
varying the number of cycles for each primer pair. Unless indicated, product
formation within the linear range is shown.
Limb micromass culture
Limb micromass cultures were set up as previously described (Kulyk et al.,
2000). Briefly, limb buds were separated from E11.5 day mouse embryos.
Embryos from crosses of Prx1cre;Tgfbr2f/wt×Tgfbr2f/f were used to generate
cultures deleted for Tgfbr2 and controls. Mesenchymal cells were dissociated
into a single cell suspension with incubation in 1 mg/ml collagenase D at 37 °C
for 1–2 h and reconstituted at a density of 1×107 cells/ml. Twenty microliters
of cell suspension was dropped into each well of a 24 well plate. After a pre-
incubation time of 1 h at 37 °C to allow cells to attach, the cultures were then
flooded with F-12:DMEM (3:2) containing 10% FBS, 50 μg/ml ascorbic acid,
10 mM β-glycerolphosphate, 2 mM glutamine, antibiotics with or without
5 ng/ml of TGFβ1 (R&D Systems). Cultures were incubated at 37 °C in CO2
incubator up to 3 days without further medium change. Following incubation,
cultures were processed for Alcian blue staining, immunofluorescence staining,
western blotting, or RT-PCR.
Alcian blue staining
Micromass cultures were rinsed with PBS and fixed with 4% paraformalde-
hyde for 15 min at room temperature at which time cells were incubated in
Alcian blue staining solution (75% ethanol–Alcian blue solution: 0.1 M
HCl=4:1) at 37 °C overnight. Finally, cells were washed with 70% ethanol.
Whole limb buds from embryos at E12.5 and E13.5 days of gestation were
also stained with Alcian blue to detect the cartilaginous skeleton (Kimmel and
Trammell, 1981). Limbs were fixed in 95% ethanol overnight and then placed in
95% ethanol–Alcian blue solution overnight to stain chondrocytes followed by
95% ethanol washes for 6 h and maceration in 1% KOH for 1–2 h. Samples
were cleared in 20, 50, and 80% glycerol in 1% KOH for 1 h for each step.
Samples were stored in 100% glycerol.
Whole mount Alizarin red–Alcian blue stains were used to determine the
skeletal structure in older embryos. Skeletons from 15.5 and 18.5 days in
gestation were double-stained for cartilage and bone with Alcian blue and
Alizarin red (Kimmel and Trammell, 1981; McLeod, 1980). All carcasses were
skinned and fixed in 95% ethanol for 24 h. Samples were then placed in 95%
ethanol–Alcian blue and Alizarin red solution (24 and 48 h respectively) for
cartilage and bone staining followed by a 95% ethanol wash (8 h) and
maceration in 1% KOH overnight at 4 °C. Samples were cleared in 20, 50, and
80% glycerol in 1% KOH for 12 h for each step. Samples were stored in 100%
glycerol.
Histology and immunofluorescence
Limb buds from E12.5, 13.5, 14.5, 15.5, and 16.5 day embryos were fixed in
4% paraformaldehyde overnight. Specimen were dehydrated in ethanol solution
and embedded in paraffin. Sections were cut at a thickness of 5 μm and mounted
on Superfrost Plus slides (Fisher). Sections were stored at 4 °C. For histological
analysis, sections were stained with hematoxylin and eosin. For immunofluor-
escence, sections were dewaxed and hydrated and then incubated with blocking
buffer (PBS with 10% goat serum) for 1 h. To examine chondrogenic
differentiation, SOX9 rabbit antibody (Santa Cruz Biotechnology) (diluted
1:1000 with blocking buffer) was added and incubated for 1 h at room
temperature. A secondary antibody consisting of goat biotinylated anti-rabbit
IgG (Vector) (diluted 1:2000 in blocking buffer) was added, and the mixture was
incubated for another 1 h. For fluorescence detection, Cy3-conjugated
streptavidin (diluted 1:2000 in block solution) was added and incubated for
1 h at room temperature. Cells were washed three times with PBS with 0.1%
Tween 20 after each step. In last step, cells were supplemented with 300 nM of
the DNA dye, YoPro, for counterstaining. For PNA staining, sections weredewaxed and hydrated and then incubated with PNA according to the protocol
of Baffi et al. (2006). Slides were washed in PBS then incubated with 10 μg/ml
rhodamine-conjugated PNA (Vector Laboratories) for 2 h at room temperature.
The slides were washed and counterstained with YoPro (Molecular Probes).
Slides were mounted with Aqua poly/Mount (Polyscience Inc.). Images were
captured with an Olympus BX-51 fluorescent microscope and macrofire digital
camera.
In situ hybridization
In situ hybridization was performed as described (Pelton et al., 1990).
Briefly, sections were hybridized to 35S-labeled anti-sense probes of Gdf5 and
Wnt9a. Gdf5 and Wnt9a probes were generated by RT-PCR and subcloned into
pGEM-T easy (Promega) cloning vector. The primers and resulting size of each
fragment are as follows: Gdf5, 248 bp, forward 5′-TGA ATA TTT GTT CAG
CCAGCG GCG-3′, reverse: 5′-TTA GGG TCT GAATGA CTG CGT GGT-3′,
Wnt9a, 237 bp, forward 5′-TTG CAA ATG CCA TGG TGT GTC TGG-3′,
reverse 5′-TCC AGG TGT ACA AGC TCT GGT GTT-3′. All inserts were
sequence verified.
Slides were exposed to KODAK Autoradiography Emulsion Type NTB
(Cat. No. 889 5666, Kodak) at 4 °C for 2 weeks and then developed by KODAK
Developer D-19 (Cat. No. 146 4593, Kodak). Sections were counterstained with
0.2% Toluidine blue. Images were obtained using an Olympus BX51
microscope and Magnafire digital camera. Images were taken under dark field
illumination (35S signal).
Cell proliferation and TUNEL labeling
To measure proliferation, BrdU staining was carried out. 60 μg/g (BrdU/
body weight) of BrdU was injected intraperitoneally into the mouse in 13.5 days
gestation, 3 h before sacrifice and removal of embryos. Rat anti-BrdU antibody
(Abcam) was used as described above for immunostaining. TdT-Frag EL™
Fragmentation Detection Kit (Calbiochem) was used according to the
manufacturer's instructions.
Results
Deletion of Tgfbr2 by Prx1Cre
To investigate the requirement of Tgfbr2 for limb develop-
ment in vivo, Tgfbr2was deleted in mouse limb buds using Cre-
mediated recombination (Sauer, 1998). Mice homozygous for
the floxed Tgfbr2 allele, Tgfbr2f/f (Chytil et al., 2002), were
crossed with mice carrying the Cre recombinase gene under
control of the Prx1 promoter (Logan et al., 2002) to generate
Prx1Cre;Tgfbr2f/wt mice. Prx1Cre;Tgfbr2f/wt mice were then
crossed to Tgfbr2f/f mice to generate Prx1Cre;Tgfbr2f/f mice.
Cre-negative mice from this cross were used as controls. To
confirm activity of Cre recombinase and estimate the level of
Cre-mediated recombination and deletion of the Tgfbr2 gene,
genomic DNA isolated from the limbs of E9.5, 10.5, 11.5, and
12.5 day Prx1Cre;Tgfbr2f/f and control embryos was used as a
template in a PCR assay that allowed for the simultaneous
detection of the wild-type (420 bp), loxP (540 bp), and deleted
(610 bp) Tgfbr2 alleles (Fig. 1A) (Baffi et al., 2004). The
presence of the Cre transgene was also determined by PCR
analysis. In the presence of Cre, significant gene deletion was
detected by E9.5 days and was maximal by E10.5 days as
indicated by the ratio of the bands for the deleted and the floxed
alleles (Fig. 1B). Only a very small amount of intact (floxed)
receptor DNA was detected after E10.5 days, likely from the
limb ectoderm, which does not express Cre. To address this
Fig. 1. Tissue specific deletion of Tgfbr2 by Prx1-Cre. The wild-type (Wt), floxed and deleted alleles of Tgfbr2 were detected by PCR using the primers indicated in
(A). (B) Genomic DNAwas isolated from whole limb buds of E9.5, E10.5, E11.5, and E12.5 day embryos of the genotypes Prx1Cre+/Tgfbr2f/w (a), Prx1Cre+/Tgfbr2f/f
(b), and Prx1Cre−/Tgfbr2f/w (c). DNAwas PCR amplified to detect the relative levels of deleted (del) (610 bp), floxed (flox) (540 bp), and wild-type (WT) (420 bp)
DNA. (C) DNAwas isolated from condensed (cond) and interdigit (non) regions from Prx1Cre+/Tgfbr2f/w (a) and Prx1Cre+/Tgfbr2f/f (b) E12.5 day limbs using laser
capture microdissection. The relative levels of floxed (flox) and deleted (del) alleles within each compartment were determined. (D) RNA was isolated from whole
limbs buds of control (c), Prx1Cre+/Tgfbr2f/w (a), and Prx1Cre+/Tgfbr2f/f (b) E10.5 day embryos and the relative levels of Tgfbr2 mRNAwere determined using semi-
quantitative RT-PCR. Primer sets directed within exon 2 (e2) and primer sets encompassing exon2 and exon3 (e2–e3) were used. Product formation is shown within
the linear range. Expression of 18S was used as a normalization control.
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removed from sections of limbs from E12.5 day embryos by
laser capture microdissection. The DNA was used in the PCR
assay described above. Essentially all of Tgfbr2 exon 2 was
deleted in the both condensed and non-condensed mesenchyme
(Fig. 1C). Finally, we determined the relative level of Tgfbr2
mRNA in total limb buds from control and Prx1Cre;Tgfbr2f/f
embryos at E10.5 days using semi-quantitative RT-PCR (Fig.
1D). Primer pairs within exon 2 (e2) or spanning exon 2 and
exon 3 (e2–e3) were used. The level of 18S was used as an
internal control. Tgfbr2 mRNA was significantly reduced in
Prx1Cre;Tgfbr2f/f limbs relative to the controls.
To confirm that the receptor was functionally deleted we
used a biological assay. Cells from E11.5 day Prx1Cre+;Tgfbr2f/f and control limbs were placed in micromass culture
and treated with 5 ng TGF-β1/ml for 3 days then stained with
Alcian blue (Fig. 2). Under our culture conditions, nodules of
Alcian blue stained chondrocytes can be seen within 3 days. In
control cultures grown without TGF- β1, Alcian blue staining
was observed only in discrete nodules (Fig. 2A). As described
previously, treatment of control cultures with TGF-β1 resulted
in diffuse staining with Alcian blue so that discrete stained
nodules were not easily detected (Fig. 2B). In contrast, the cells
from Prx1Cre+;Tgfbr2f/f limbs did not respond to exogenously
added TGF-β1 and discrete Alcian blue stained nodules similar
to that seen in the untreated samples were observed (Figs. 2C, D)
suggesting functional deletion of the receptor by E11.5 days.
Furthermore, the nodules that formed in the Prx1Cre+;Tgfbr2f/f
Fig. 2. Functional assay for the deletion of Tgfbr2. Limb mesenchyme from control Cre-negative (A, B) and Prx1Cre+/Tgfbr2f/f (C, D) E11.5 day (Theiler stage 19)
embryos was placed in micromass culture in the absence (A, C) or presence (B, D) of 5 ng TGF-β1/ml for 3 days at which time the cells were stained with Alcian blue.
In control, untreated Tgfbr2 positive cultures, discreet nodules of condensed mesenchyme stained with Alcian blue were observed. As previously described, TGF-β1
treated cells showed diffuse Alcian blue staining through the whole culture so that discreet nodules were difficult to detect. Cultures from Prx1Cre+/Tgfbr2f/f limbs did
not respond to TGF-β1 and an increased number of nodules as well as more intense staining were observed relative to cultures from control mice.
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in the control cultures suggesting that Tgfbr2 is not required for
induction of chondrocyte differentiation and that Tgfbr2
normally acts to limit chondrogenesis in limb mesenchyme
(Figs. 2A, C).
Deletion of Tgfbr2 results in alterations in the development of
the long bones after E13.5 days
Next, limb buds from embryos of each genotype at
E12.5 days were stained with Alcian blue to examine the
developing skeletal elements (Figs. 3A–C). Interestingly, limbs
in Prx1Cre+;Tgfbr2f/f embryos looked similar to those from
Prx1Cre+;Tgfbr2f/w and control (Prx1Cre−;Tgfbr2f/w) embryos
(Figs. 3A–C). The size, shape, and pattern of the limb, the
thickness, and Alcian blue staining in Prx1Cre+;Tgfbr2f/f limbs
were very similar to the Prx1Cre-negative control limbs at this
stage (Figs. 3A–C). Alterations were not detected in the
organization of the developing cartilage as determined by H&E
staining (Figs. 3D–F). Furthermore, alterations in the localiza-
tion or expression of Sox9 were not detected by immuno-
fluorescent staining in sections from control and Prx1Cre+/
Tgfbr2f/f limbs (Figs. 3G–I). The data suggest that Tgfbr2 is
not uniquely required in the limb mesenchyme after E10.5 days
for the formation of cartilage or the patterning of the limb.
Next, we examined Prx1Cre+;Tgfbr2f/f mice at later stages of
development to see if Tgfbr2 was required for any of the
subsequent steps of skeletal development (Figs. 4, 5). Prx1Cre+;
Tgfbr2f/f mice were dead at birth with short limbs, open sternum,
and open skull (Fig. 4A). Alcian blue and Alizarin red stainedskeletons from E18.5 day embryos showed the details of these
defects in skeletal development (Fig. 4B). In the skull, the
parietal bones and frontal bones were either missing or reduced
in size, suggesting a defect in intramembraneous bone formation
(Figs. 4E, F). Since Prx1-Cre is not expressed in the base of the
skull, or the axial skeleton, these bones developed normally.
Prx1-Cre is expressed in the ventral mesoderm where the
sternum forms and thus Prx1Cre+;Tgfbr2f/f embryos had a split
sternum, a phenotype similar but more severe than mice with a
null mutation in the Tgfb2 ligand (Fig. 4C, Sanford et al., 1997).
At E18.5 days, limbs of the mutant embryos were obviously
shorter than controls (Figs. 4B and 5A). Shortening of the limbs
was variable at E15.5 days (Fig. 4D) but was consistently
observed by E16.5 days (data not shown). Furthermore, the
deltoid tuberosity did not develop on the humerus of mutant
mice (Figs. 4D and 5A).
Since an overall reduction in the length of the mutant long
bones was observed starting at E15.5 days and obvious by
E16.5 days (Fig. 5), we tested the hypothesis that deletion of
Tgfbr2 results in alterations in proliferation and/or hypertrophic
differentiation. The level of proliferation fromcontrol andmutant
limbs was measured by BrdU incorporation. At E13.5 days, the
number of proliferating chondrocytes was comparable in control
andmutantmice (Fig. 5B).However, byE15.5days, proliferation
was significantly reduced inmutant cartilage (Fig. 5C) relative to
controls. These data suggest that reduced proliferation in
chondrocytes contributes to the decreased length of the limbs in
Prx1Cre+;Tgfbr2f/f mice.
Next, we looked at hypertrophic differentiation. Within the
growth plate, prehypertrophic chondrocytes stop proliferating
Fig. 3. Early skeletal development in Prx1Cre+/Tgfbr2f/f mice. (A–C) Alcian blue stained hindlimbs (A–C), H&E stained (D–F), and Sox9 stained (G–I) sections were
prepared from E12.5 day control Prx1Cre−/Tgfbr2f/w (A, D, G), Prx1Cre+/Tgfbr2f/w (B, E, H), and experimental Prx1Cre+/Tgfbr2f/f (C, F, I) embryos. Initiation of
skeletal development occurred in all three cases. Sox9 staining was comparable in all three genotypes (G–I).
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growth plate. By E16.5 to 18.5 days, alterations were readily
detected in the growth plates of mutant embryos (Figs. 5A, D,
E). Mutants demonstrated an expanded zone of hypertrophy
relative to controls. That is, the hypertrophic zone represented
a greater portion of the total growth plate in mutants (Figs. 5D
arrows, E solid lines; (c /b+c)×100=percentage of the growth
plate occupied by the hypertrophic zone). At E16.5 days, the
hypertrophic zone represented an average of 29% of the total
growth plate while 43% of the total growth plate was occupied
by the hypertrophic zone in mutant mice (t-test p=1.2×10−4).
At E18.5 days, the hypertrophic zone represented 19% of the
total growth plate in controls and 41% in mutants (t-test
p=2.9×10−5). The expanded hypertrophic zone appeared to
be the result of a combination of accelerated conversion of
chondrocytes from the prehypertrophic to the hypertrophic
zone and a failure of late hypertrophic differentiation.
Accelerated early hypertrophic differentiation is suggested
by the decrease in the distance from the top of the bone to the
beginning of the hypertrophic zone (see line b in Fig. 5E). A
delay in the formation of the marrow cavity and trabecular
bone is suggested by a decrease in the length of the Alizarin
red stained portion of the bones starting at E15.5 days(Figs. 4D and 5A, E). Percent mineralization was measured as
the length of the Alizarin red stained portion over the total
length of the bone. At E16.5 days, 31% of the bone was
mineralized in controls while only 14% was mineralized in
mutants (t-test p=7.6×10−4; this can also be seen in Fig. 5E
line d/a). At E18.5 days, an average of 51% of the control and
35% of the mutant long bones were mineralized (t-test
p=1.2×10−7). This result suggests that TGFβ signaling is
required for proper hypertrophic differentiation.
Deletion of Tgfbr2 results in defects in the maintenance of the
interzone
Another defect observed in Prx1Cre+/Tgfbr2f/f limbs was
that the joints in the phalanges of the forelimb and some in the
hindlimb were fused while other more proximal joints in the
limb were normal (Figs. 6A–C). The difference in the forelimb
and hindlimb joints is likely a result of delayed and reduced
Prx1-Cre expression in the hindlimb as previously described
(Logan et al., 2002). At E13.5 days a clear line within the
Alcian blue stained phalange representing the interzone was
apparent in both control and mutant mice (Fig. 6A, arrows);
however, by E15.5 days the interzone was not detected and the
Fig. 4. Analysis of the skeletal phenotype of in Prx1Cre+/Tgfbr2f/f embryos. (A) Gross appearance of newborn mice. Mutant newborns had very short limbs and
were missing the parietal bone. (B–F) Alizarin red/Alcian blue stained skeletal preparations. Gross appearance of whole E18.5 day embryos is shown in (B). The
sternal elements were split in the Prx1Cre+/Tgfbr2f/f mice (arrows, C). The deltoid tuberosity was missing, the joints in the autopod were fused, and there was
reduced mineralization by E15.5 days (D). The parietal bones and frontal bone were missing or reduced in size in the skull of Prx1Cre+/Tgfbr2f/f embryos (top view
E, side view F).
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develops within a continuous sheet of chondrocytes. The joint
site is specified and the cells within this area form the
interzone. The interzone consists of condensed flat cells that
can be easily distinguished from the round cells of the cartilage
(Fig. 6D, arrow). Specification of the joint occurs between
E12.5 and E13.5 days and is thought to involve the activity of
Wnt9a (reviewed in Pacifici et al., 2005). The interzone is
characterized by distinct gene expression patterns. One of the
markers of interzone is GDF5, which is also required to
maintain the developing joint. The next step, cavitation, occurs
between E14.5 and E15.5 (Fig. 6E). Some of the cells in the
interzone undergo apoptosis to form the joint space. Next,
morphogenesis of the joint to the proper shape occurs (Fig. 6F).
Cells that resembled flat cells of the interzone were visible in
Prx1Cre+;Tgfbr2f/f limbs at E13.5 days (Fig. 6D, arrow);
however, by E14.5 days the presence of the cells was variable
and they were difficult to find (Fig. 6E). In most cases the
darkly staining cells were small and round like immaturecartilage. In some cases the cells were large and appeared
hypertrophic (Figs. 6E and 8B, C). By E16.5 days, the joints
were completely fused.
Next, to determine at which step development of the joint
was disrupted we looked at markers of early joint formation
(Fig. 7). To examine whether Tgfbr2 is required for the
specification, initiation or maintenance of the interzone, we
analyzed the expression of Wnt9a and GDF5 in the digits of
control and Prx1Cre+;Tgfbr2f/f embryos at E12.5, E13.5,
E.14.5, and E15.5 day limbs (Fig. 7). Sections from control
and Prx1Cre+;Tgfbr2f/f embryos were hybridized to 35S-labeled
probes for Gdf5 and Wnt9a. In control joints, Gdf5 mRNAwas
detected as early as E12.5 days (not shown) and expression
persisted until at least E15.5 days (Figs. 7A, C, E). Expression
was limited to a very discreet line of cells representing the
interzone. Although Gdf5 expression was comparable in control
and mutant limbs up to E13.5 days (Figs. 7A, B) by E14.5 days,
Gdf5 expression was reduced in the interzone of mutant limbs
and ectopic expression was found in the perichondrium along
Fig. 5. Characterization of the growth plate phenotype in Prx1Cre+/Tgfbr2f/f mice. (A) Alizarin/Alcian blue skeletal preparations of E18.5 day control and Prx1Cre+/
Tgfbr2f/f limbs showing the reduced size of the limb. (B, C) Chondrocyte proliferation. Incorporation of BrdU into E13.5 (B) and E15.5 (C) day long bones was
measured by immunofluorescence (red). Cells were counterstained with YoPro (green). Proliferation was dramatically reduced by E15.5 days. (D, E) Organization of
the growth plate. Close-up of the growth plate from the distal radius and ulna in Alizarin red/Alcian blue E18.5 day control and mutant mice (D). The hypertrophic zone
is bracketed by small arrows. H&E stained sections from the ulna of E16.5 day control and mutant limbs (E). The total length of the bone is marked with the double
arrows (a). The distance from the top of the bone to the start of the hypertrophic zone (b), the hypertrophic zone (c), and the marrow cavity/trabecular bone (d) are
marked.
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pattern was even more pronounced by E15.5 days when GDF5
expression in the presumptive joint area was barely detectable
(Figs. 7E, F). Similar results were found for the expression of
Wnt9a mRNA (Figs. 7G, H). These results suggest that
Tgfbr2 is not required for specification or initiation of the
joint but may be required to maintain the interzone.
Previously, we showed that deletion of Tgfbr2 in the
mesenchyme of the axial skeleton results in defects in the
formation of the intervertebral disc (IVD) (Baffi et al., 2004).
Specifically, markers of the annulus fibrosus phenotype were
lost and peanut agglutinin (PNA) stained cartilage was found in
the area of the developing IVD (Baffi et al., 2004). PNA is a
lectin that recognizes β-galactose (1–3) N-acetyl galactosamine
residues. It is commonly used to detect chondrogenic tissues
and can detect chondrogenic cells before the overt deposition
of cartilage specific matrix and staining with Alcian blue
(Bagnall and Sanders, 1989; DeLise and Tuan, 2002; Stringa
and Tuan, 1996). To determine if the defects in development
of the joint were due to cartilage differentiation in the
interzone, which normally contains non-cartilaginous cells,
PNA staining was used (Fig. 8). As described above, in control
cells, the interzone was clearly seen as a strip of lightly stained
cells in the region where the new joint will form (Fig. 8A).
Cavitation was evident at this stage (inset Fig. 8A). In contrast,the lightly stained cells of the interzone were not detected in
the autopods of Prx1Cre+/Tgfbr2f/f mice (Figs. 8B, C). When
control cells were stained with PNA, a clear, unstained section
of cells corresponding to the interzone was observed inside a
rectangle of PNA stained cells representing the cartilage on
either side of the joint (Fig. 8D). A clear boundary between the
stained cartilage and unstained interzone was seen. In contrast,
PNA staining was observed throughout this area in the
Prx1Cre+/Tgfbr2f/f limbs. Clear boundaries were not detected
(Figs. 8E, F). The results suggest that Tgfbr2 is required to
maintain the interzone by preventing the mesenchymal cells of
the interzone from differentiating into cartilage and/or by
forming a boundary between cartilage and interzone.
Cells in the interzone undergo apoptosis as part of cavitation
to form the joint space. Apoptosis was not detected in this area
in control or mutant limbs at E12.5 or E13.5 days (data not
shown). Apoptosis was detected by TUNEL staining in the
interzone of control limbs at E14.5 and E15.5 days (Figs. 9A,
C). TUNEL positive cells were not detected in this area within
mutant limbs (Figs. 9B, D) although normal staining was
observed in the interdigit mesenchyme. Since non-cartilagenous
interzone cells normally undergo apoptosis, the lack of
apoptosis in this region is likely a consequence of the fact
that the interzone is not maintained and that this zone has been
replaced with cartilage. Together the results suggest that TGF-β
Fig. 6. Characterization of the joint phenotype in Prx1Cre+/Tgfbr2f/f mice. (A–C) Whole mount skeletal preparations of the forelimb autopod in control and Prx1Cre+/
Tgfbr2f/f mice at E13.5 (A), E15.5 (B), and E18.5 (C) days. The area denoting the developing joint is marked with an arrow. (D–F) H&E stained sections of the
forelimb autopod from control and mutant mice at E13.5 (D), E14.5 (E), and E16.6 (F) days. The interzone is marked with the large arrow.
312 H.-S. Seo, R. Serra / Developmental Biology 310 (2007) 304–316regulates joint formation at a point after the specification and
initiation of the interzone that blocks the subsequent cavitation
of the joint.
Discussion
Chondrogenesis is a series of consecutive and strictly
regulated steps that starts with condensation of mesenchyme
followed by differentiation of cells into chondrocytes. The
factors that regulate the early stages of chondrogenesis are just
beginning to be elucidated. Several previous reports suggested
that TGF-β plays a critical role in early chondrogenesis
including mesenchymal condensation (Carrington and Reddi,
1990; Chimal-Monroy and Diaz de Leon, 1997; Kulyk et al.,
1989; Leonard et al., 1991; Macias et al., 1999; Roark and
Greer, 1994; Verrecchia and Mauviel, 2002). It was shown that
TGF-β is sufficient to induce the accumulation of Alcian blue
stained matrix in micromass cultures derived from chick or
mouse limbs. Even though the cells did not obtain a typical
chondrocyte morphology like that observed in BMP treated
cultures (Hatakeyama et al., 2004), it was concluded that
TGF-β acts as a pro-chondrogenic factor. Furthermore, the
effects of TGF-β were initiated in a specific window of time
during culture suggesting that TGF-β affected the earliest
stages of chondrogenesis including mesenchymal condensa-
tion (Carrington and Reddi, 1990; Chimal-Monroy and Diazde Leon, 1997; Kulyk et al., 1989; Leonard et al., 1991;
Macias et al., 1999; Roark and Greer, 1994; Verrecchia and
Mauviel, 2002). Since the previous conclusions were based on
gain-of-function experiments using in vitro systems, we
wanted to determine the normal role TGF-β in limb de-
velopment using loss-of-function experiments. To this end we
used conditional deletion of Tgfbr2 in limb mesenchyme.
Mice that express the Cre recombinase under control of Prx1
promoter were crossed to mice in which exon 2 of Tgfbr2 was
flanked with loxP sites, resulting in conditional deletion of
Tgfbr2 primarily in limb mesenchyme (Chytil et al., 2002;
Logan et al., 2002). Previous studies have shown that this Cre
strain results in complete deletion of a reporter gene in the
forelimb mesenchyme by E9.5 days and the hindlimb
mesenchyme by E10.5 days (Logan et al., 2002). We showed
significant deletion of Tgfbr2 exon 2 DNA by E9.5 days and
maximal deletion of receptor DNA by E10.5 days. The half-
life of the TGF-β type II receptor protein has been estimated
to be between 1 and 3 h (Koli and Arteaga, 1997; Wells et al.,
1997) while the half-life of the mRNA is estimated between 1
and 5 h (Jiang et al., 1997). RT-PCR studies also indicated a
significant reduction in the level of Tgfbr2 mRNA in the limb
of Prx1Cre+/Tgfbr2f/f mice relative to controls at E10.5 days.
Deletion of the receptor protein was confirmed using a
functional assay. Limb mesenchyme from E11.5 day mice did
not respond to exogenously added TGF-β1 confirming the
Fig. 7. GDF5 and Wnt9a expression in Prx1Cre+/Tgfbr2f/f mice. Sections of
phalanges of E13.5, 14.5, and 15.5 day control (A, C, E, G) and Prx1Cre+/
Tgfbr2f/f (B, D, F, H) mice were hybridized to an anti-sense probe for GDF5
(A–F) and Wnt9a (G, H) mRNA. Arrows and arrowheads indicate staining in
the interzone cells and perichondrium, respectively. GDF5 expression was first
detected at E12.5 (data not shown). Expression increased over time and defined
the interzone in control limbs (A, C, E). In mutant limbs, GDF5 expression in
interzone cells was reduced over time (arrows, B, D, F). In addition, ectopic
GDF5 expression was detected in the perichondrium of the developing
phalanges (arrowheads, B, D, and F). Wnt9a showed the same expression
pattern with GDF5 (G, H and data not shown).
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collagen and limb cartilage are first detected in the limb
between E11.5 and E12.5 days (Ovchinnikov et al., 2000).
Since the receptor protein is expressed at very low levels in
vivo and difficult to detect even in wild-type mice, the
functional assay is more sensitive than looking at protein
levels alone. Furthermore, Activin and Activin receptors arepresent in limb mesenchyme (Nohno et al., 1993) and are
known to activate Smad2 and Smad3, therefore, the phosphor-
ylation level of Smad2/3 cannot be used as a specific assay for
TGF-β receptor function in the limb (Hoodless et al., 1996;
Kretzschmar et al., 1997; Macias-Silva et al., 1996; Moustakas
et al., 2001; Nakao et al., 1997).
Mice in which Tgfbr2 was deleted in Prx1-Cre expressing
cells demonstrated defects in the development of the long bones
of the limb as well as defects in the development of the sternum
and parietal bones of the skull. In addition to expression in the
limb, Prx1-Cre is expressed in the anterior cranial mesoderm as
well as the ventral mesoderm in the trunk explaining defects in
the skull and sternum (Logan et al., 2002). Defects in the
parietal bones in the skull suggest a defect in intramembranous
bone formation. It has long been suggested that TGF-β plays an
important role in osteoblast differentiation. It was previously
shown that mice with germ-line deletion of Tgfb2 ligand
demonstrate defects in the development of the sternum that are
similar to but less severe than the defect described here (Sanford
et al., 1997). Similar mild defects were seen in mice expressing
a dominant-negative form of Tgfbr2 (Serra et al., 1997). It is not
clear how TGF-β regulates the development of the sternum.
This study focused on defects in the development of the long
bones, which include shortened bones, absence of the deltoid
tuberosity, and fusion of the joints in the autopod.
It was previously shown that muscle activity is required for
the formation of the deltoid tuberosity (reviewed in Herring,
1994). Denervation and subsequent paralysis of the forelimb
in rats resulted in a smaller deltoid tuberosity compared to the
contra-lateral mobile side (Dysart et al., 1989). The results
suggested that mechanical tension induced by the muscle is
required to maintain the deltoid tuberosity. Furthermore,
mouse embryos lacking striated muscle as a result of dis-
ruption of Myf5 and MyoD, master regulators of muscle
differentiation, demonstrate defects in several skeletal struc-
tures including the deltoid tuberosity suggesting an important
role for mechanical force in the development of the deltoid
tuberosity (Rot-Nikcevic et al., 2006). Although the muscle in
the limb does not express Prx1-Cre (Logan et al., 2002 and
our unpublished observations), it is expressed in the
connective tissue cells that pattern the muscle leaving
alterations in muscle activity a possible cause for the absence
of the deltoid tuberosity. In addition to the expression
described in the skeletal elements, Prx1-Cre is also expressed
in the tendon that attaches the bone to the muscle so that the
defect in the deltoid tuberosity could also be due to alterations
in the attachment of the muscle to the bone as well as in the
morphogenesis of the skeleton itself. Additional experiments
looking at markers of tendon and muscle differentiation will
address this issue.
Although Tgfbr2 was significantly depleted by E10.5 days in
Cre expressing mice, the size and shape of the early skeletal
elements were similar to controls. The organization of the
cartilage and expression of Sox9 were also comparable. The
results suggest that Tgfbr2 is not uniquely required for the
initiation of limb chondrogenesis or patterning of the limb at
least after E10.5 days when we detect very high levels of Tgfbr2
Fig. 8. Cartilage replaces interzone in E15.5 day Prx1Cre+/Tgfbr2f/f embryos. Sections from control (A, D) and Prx1Cre+/Tgfbr2f/f (B, C, E, F) E15.5 day limbs were
stained with H&E (A–C) or PNA (D–F). PNA stained sections were counterstained with YoPro, a green nuclear stain. The red channel, indicating PNA staining, is
shown alone (red) as well as merged with the green nuclear stain (merge). Insets in panels A–C show close-up images of the joint region. Asterisks are next to the joint
region shown in the inset.
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sclerotome of the axial skeleton also does not affect the
initiation of chondrogenesis (Baffi et al., 2006).
Loss of Tgfbr2 in the limb mesenchyme resulted in distinctly
shorter limbs. This is in contrast to previous studies in which
Tgfbr2 was deleted using Col2a-Cre (Baffi et al., 2004).
Alterations in bone length, area of mineralization, hypertrophic
differentiation or chondrocyte proliferation were not detected in
Col2acre:Tgfbr2lox/lox newborn mice. The differences in
phenotypes observed in the two mouse models are likely due
to the localization and timing of Prx1- and Col2a-Cre-mediated
recombination. Prx1-Cre is expressed in early limb mesench-
yme starting at E9.5 days of gestation and thus recombination is
targeted to both chondrocytes and perichondium (Logan et al.,
2002). Col2a-Cre is expressed later in the limbs, after cells have
committed to the chondrocyte lineage, and the perichondrium is
not efficiently targeted (Ovchinnikov et al., 2000; Baffi et al.,
2004). There is considerable evidence indicating the importance
of the perichondrium in coordinating development of the long
bone and specifically implicating a role for TGF-β in the
perichondrium (Alvarez et al., 2001; Alvarez et al., 2002;
Di Nino et al., 2001; Long and Linsenmayer, 1998; Serra et al.,
1997). Comparisons of the phenotype in these two mouse
models also support a role for the perichondrium in mediating
the effects of TGF-β on embryonic endochondral bone
formation.We also show here that loss of Tgfbr2 results in a failure of
the joints to form in the autopod. Marker analysis suggests that
the joint is specified and that the interzone initially forms but is
not maintained since GDF5 expression is reduced and PNA
stained cells are present in the area of the interzone.
Furthermore, apoptosis is not seen in the interzone at the
initiation of cavitation. Likewise, we previously showed that
deletion of Tgfbr2 in the axial skeleton results in a defect in the
formation and maintenance of the IVD (Baffi et al., 2006; Baffi
et al., 2004). Specifically, loss of Tgfbr2 in the axial skeleton
resulted in the loss of the boundary between the vertebrae and
IVD so that the IVD space contained cartilage. The previous
results suggested that Tgfbr2 has two potential roles in the axial
skeleton (1) to promote the differentiation of cells in the IVD
and (2) to limit cartilage differentiation in the IVD space (Baffi
et al., 2006). Similarly, we propose that TGF-β normally acts in
development of the autopod joint by limiting the formation of
cartilage in the interzone space and/or by maintaining the
boundary between the cartilage and the interzone so that the
joint can ultimately form (Archer et al., 2003; Lamb et al., 2003;
Pacifici et al., 2005).
Along these lines, micromass cultures of limb mesenchyme
from Prx1Cre+/Tgfbr2f/f mice consistently demonstrated an
increase in the number and intensity of Alcian blue stained
nodules when compared to cultures from Cre-negative mice.
The results were at first surprising and suggest that Tgfbr2
Fig. 9. Reduced apoptosis in Prx1Cre+/Tgfbr2f/f joints. Apoptotic cells were measured by TUNEL assay on sections from control (A, C) and Prx1Cre+/Tgfbr2f/f
embryos (B, D) at E14.5 (A, B) and E15.5 (C, D) days. Apoptosis was seen in the interzone of the developing joint in control limbs. No apoptotic cells were detected in
the presumptive joint area of mutant E14.5 and E15.5 day embryos. We did not detect apoptotic cells in control or mutant joints at E13.5 days (not shown).
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This result does not contradict the previous findings from gain-
of-function experiments but offers a new interpretation of the
data based on loss-of-function experiments using both in vitro
and in vivo models. We propose that TGF-β is not pro-
chondrogenic at the stages of development examined here, due
to the timing of Prx-Cre expression our results do not exclude a
role for Tgfbr2 in initiating chondrogenesis before E10.5 days.
But instead, we propose that TGF-β normally acts to limit
chondrogenesis and promote maintenance of connective tissues
that are similar but distinct from cartilage, for example, annulus
fibrosus of the intervertebral disc and interzone of the synovial
joint (Lamb et al., 2003). The model in which TGF-β limits
chondrogenesis and promotes other connective tissue pheno-
types would also help to explain why TGF-β1 treated limb
mesenchyme does not obtain chondrocyte morphology or
discreet Alcian blue stained nodules like those observed in
BMP treated cultures (Chimal-Monroy and Diaz de Leon,
1997). In summary, the results presented here provide
information regarding signaling through Tgfbr2 and mechan-
isms of development in mouse limb development.
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